Table of Content

Open Access

ARTICLE

Two‐year evolution of latent rheumatic heart disease in Malawi

Amy Sanyahumbi1, Andrea Beaton2, Danielle Guffey3, Mina C. Hosseinipour4, Melissa Karlsten1, Charles G. Minard3, Daniel J. Penny1, Craig A. Sable5, Peter N. Kazembe6
1 Division of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, Houston, Texas
2 Department of Pediatric Cardiology, Heart Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
3 Dan L Duncan Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas
4 Department of Infectious Disease, University of North Carolina Project, University of North Carolina, Lilongwe, Malawi
5 Department of Pediatric Cardiology, Children’s National Heart Institute, Children’s National Medical Center, Washington, District of Columbia
6 Department of Pediatrics, Baylor College of Medicine Clinical Center of Excellence, Lilongwe, Malawi
* Corresponding Author: Amy Sanyahumbi, Division of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, 6621 Fannin St., 19th floor, Houston, TX 77030. Email:

Congenital Heart Disease 2019, 14(4), 614-618. https://doi.org/10.1111/chd.12756

Abstract

Background: In asymptomatic children, screening echocardiography has been used to attempt to diagnose rheumatic heart disease (RHD) at an early stage (latent RHD). World Heart Federation guidelines have standardized categorization of “definite,” “borderline,” or no RHD by echo findings. The progression of RHD diagnosed through echo screening is not known. In 2014, we screened 1450 schoolchildren in Malawi.
Objective: Our objective was to evaluate 2‐year RHD evolution among those diag‐ nosed through screening.
Methods: Two‐year follow‐up echocardiograms of those diagnosed with latent RHD were read by a primary, secondary, then third reader if there was disagreement. Progression or regression of both definite and borderline groups were tabulated. Penicillin adherence, age, gender, number in home, and household income were com‐ pared between those with definite RHD who regressed to borderline and those that stayed definite. We utilized the local system used to track HIV defaulters in order to bring participants back into care. Comparisons were made using Fisher’s exact and Wilcoxon rank‐sum tests.
Results: Of the 39 with borderline RHD, 1 was lost to follow‐up (2.6%), 1 progressed to definite (2.6%), 19 remained borderline (48.7%), 17 (43.6%) regressed to normal, and 1 was reclassified as mitral valve prolapse (2.6%). Of the 11 with definite RHD, 6 (54.5%) remained definite, 4 regressed to borderline (36.4%), and 1 regressed to nor‐ mal (9.1%). Two of 11 with definite RHD had penicillin adherence above 80% for the 2‐year follow‐up period. There were no differences in adherence, gender, age, house‐ hold income, or number in household between those with definite RHD that re‐ gressed to borderline and those who did not (P > .19).
Conclusions: Borderlines had a very low progression rate to definite RHD. A strength of our study was a high retention rate (98%). Longer follow‐up is needed to determine expected disease evolution.

Keywords

echocardiography, global health, pediatric cardiology, rheumatic heart disease, screening

Cite This Article

Sanyahumbi, A., Beaton, A., Guffey, D., Hosseinipour, M. C., Karlsten, M. et al. (2019). Two‐year evolution of latent rheumatic heart disease in Malawi. Congenital Heart Disease, 14(4), 614–618.



This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 944

    View

  • 754

    Download

  • 0

    Like

Related articles

Share Link

WeChat scan